The Clinical Study of Acute Pancreatitis Treated by TongFuSan

Overview

The purpose of this study is to determine whether TongFuSan is effective in the treatment of acute pancreatitis with gastrointestinal dysfunction.

Full Title of Study: “The Clinical Study of Acute Pancreatitis With Gastrointestinal Dysfunction Treated by TongFuSan for External Application on ShenQue Acupoint”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: October 2014

Detailed Description

– Patient who is diagnosed with acute pancreatitis(AP) should be included. – Patients will be divided into two groups as random number table: control group(A) and experimental group(B). – Group A will be given Mosapride po,and group B will be given TongFusan except for basic treatments of AP. – Same investigator will write the case report form. – Investigator will collect the patients' blood in three points: on admission, the third day and the seventh day. – Otherwise, we need write down patients' clinical manifestation,Traditional Chinese Medicine differentiation, the result of clinical tests. – When the patient discharge, we will write down the treatment measures, therapeutic effect, length of stay and the costs.

Interventions

  • Drug: TongFuSan
    • TongFuSan 1g

Arms, Groups and Cohorts

  • Experimental: TongFuSan
    • TongFuSan 1g per time, change every day, the duration is seven days

Clinical Trial Outcome Measures

Primary Measures

  • the time of first defecation
    • Time Frame: ten days

Secondary Measures

  • the time of bowel sounds getting back to normal
    • Time Frame: ten days

Participating in This Clinical Trial

Inclusion Criteria

  • clinical diagnosis of acute pancreatitis,both mild type and severe type Exclusion Criteria:

  • pregnant or suckling – cancer in late time – patient near death

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Beijing Friendship Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: miaobin, associate chief physician – Beijing Friendship Hospital
  • Overall Official(s)
    • Bin Miao, PHD, Study Chair, Beijing Friendship Hospital
    • Hong Wang, Graduate, Study Director, Beijing Friendship Hospital
    • Shuwen Zhang, bachelor, Study Director, Beijing Friendship Hospital
    • Chao Wang, PHD, Principal Investigator, Beijing Friendship Hospital
    • Yanli Su, PHD, Principal Investigator, Beijing Friendship Hospital
    • Shirong Li, graduate, Principal Investigator, Beijing Friendship Hospital
    • Fengwu Li, graduate, Principal Investigator, Beijing Friendship Hospital
    • Dinghua Xu, graduate, Principal Investigator, Beijing Friendship Hospital
  • Overall Contact(s)
    • Hong You, PHD, 010-63139197

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.